SUVRETTA CAPITAL MANAGEMENT, LLC - 26 Mar 2025 SCHEDULE 13D/A Report for Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC)

Filing Manager
SUVRETTA CAPITAL MANAGEMENT, LLC
Reporting Manager
SUVRETTA CAPITAL MANAGEMENT, LLC
Security
Benitec Biopharma Inc. Common Stock, par value $0.0001
Symbol
BNTC
Shares outstanding
31,309,938 shares
Disclosed Ownership
15,623,659 shares
Ownership
50%
Form type
SCHEDULE 13D/A
Filing time
28 Mar 2025, 16:50:57 UTC
Date of event
26 Mar 2025
Next filing
10 Nov 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SUVRETTA CAPITAL MANAGEMENT, LLC 50% 15,623,659 0 15,623,659 /s/ Andrew Nathanson SUVRETTA CAPITAL MANAGEMENT, LLC 0001569064
Averill Master Fund, Ltd. 44% 13,922,844 0 13,922,844 /s/ Andrew Nathanson Averill Master Fund, Ltd. 0001939329
Averill Madison Master Fund, Ltd. 5.4% 1,700,815 0 1,700,815 /s/ Andrew Nathanson Averill Madison Master Fund, Ltd. 0002021243
Aaron Cowen 50% 15,623,659 0 15,623,659 /s/ Aaron Cowen Aaron Cowen